These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12662411)

  • 61. Evidence that protease inhibitors reduce the degradation of parathyroid hormone and calcitonin injected subcutaneously.
    Parsons JA; Rafferty B; Stevenson RW; Zanelli JM
    Br J Pharmacol; 1979 May; 66(1):25-32. PubMed ID: 313228
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changes in parathyroid hormone during haemodialysis sessions with two different dialysis membranes: specific adsorption of intact parathyroid hormone.
    Valat C; Pengloan J; Blanchier D; Bagros P; Besnard JC
    Nucl Med Commun; 1993 Feb; 14(2):130-6. PubMed ID: 8429992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of a protease inhibitor on bacterial multiplication].
    Gastaldi G; Mattiello A
    Pathologica; 1971; 63(923):223-31. PubMed ID: 5005231
    [No Abstract]   [Full Text] [Related]  

  • 64. Thrombin-mediated degradation of parathyroid hormone in serum tubes.
    La'ulu SL; Straseski JA; Schmidt RL; Genzen JR
    Clin Chim Acta; 2014 Nov; 437():191-6. PubMed ID: 25086279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of separator gel in Sarstedt S-Monovette® serum tubes on various therapeutic drugs, hormones, and proteins.
    Schouwers S; Brandt I; Willemse J; Van Regenmortel N; Uyttenbroeck W; Wauters A; Neels H
    Clin Chim Acta; 2012 Jan; 413(1-2):100-4. PubMed ID: 21945632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of protease inhibitors containing tubes for MS-based plasma peptide profiling studies.
    Pérez V; Juega-Mariño J; Bonjoch A; Negredo E; Clotet B; Romero R; Bonet J
    J Clin Lab Anal; 2014 Sep; 28(5):364-7. PubMed ID: 24648264
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review.
    Hanon EA; Sturgeon CM; Lamb EJ
    Clin Chem Lab Med; 2013 Oct; 51(10):1925-41. PubMed ID: 24072573
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alternative pre-analytic sample handling techniques for glucose measurement in the absence of fluoride tubes in low resource settings.
    Nakanga WP; Balungi P; Niwaha AJ; Shields BM; Hughes P; Andrews RC; Mc Donald TJ; Nyirenda MJ; Hattersley AT
    PLoS One; 2022; 17(2):e0264432. PubMed ID: 35226681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Collection of cerebrospinal fluid into EDTA versus plain tubes does not affect the standard analysis in dogs.
    Koch BC; Daniels LO; Thomsen LT; Nielsen MBM; Berendt M; Gredal H
    Acta Vet Scand; 2019 May; 61(1):23. PubMed ID: 31060616
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stability of parathyroid hormone in blood from renal patients on haemodialysis.
    Walker KS; Seth J
    Ann Clin Biochem; 2000 Nov; 37 ( Pt 6)():800-1. PubMed ID: 11085628
    [No Abstract]   [Full Text] [Related]  

  • 71. The effect of anticoagulants, enzyme inhibitors and long term storage on the extraction of known concentrations of methionine enkephalin in human plasma.
    Saad E; Tebb HM; Ashton KJ; Bromham DR
    Life Sci; 1989; 44(10):683-7. PubMed ID: 2467157
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The influence of the protease inhibitor aprotinin on tumor invasion of three cell lines in vitro.
    Prange E; Schroyens W; Pralle H
    Clin Exp Metastasis; 1988; 6(2):107-13. PubMed ID: 2449988
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Protective effect of a protease inhibitor "Aprotinin" on acute ischemic myocardium].
    Tanaka H; Okamura T; Suzuki T; Sunamori M; Suzuki A
    Rinsho Kyobu Geka; 1984 Sep; 4(5):544-9. PubMed ID: 6084298
    [No Abstract]   [Full Text] [Related]  

  • 74. Preservative effect of aprotinin on canine plasma immunoreactive adrenocorticotropin concentrations.
    Kemppainen RJ; Clark TP; Peterson ME
    Domest Anim Endocrinol; 1994 Oct; 11(4):355-62. PubMed ID: 7530181
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stability of Bio-Intact (1-84) parathyroid hormone ex vivo in serum and EDTA plasma from hemodialysis patients.
    Teal TK; Wood JL; Stevens PE; Lamb EJ
    Clin Chem; 2004 Sep; 50(9):1713-4. PubMed ID: 15331521
    [No Abstract]   [Full Text] [Related]  

  • 76. [Glucagon degrading activity].
    Wakasugi K
    Nihon Naibunpi Gakkai Zasshi; 1989 May; 65(5):483-96. PubMed ID: 2476336
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of sample handling methods on substance P concentrations and immunoreactivity in bovine blood samples.
    Mosher RA; Coetzee JF; Allen PS; Havel JA; Griffith GR; Wang C
    Am J Vet Res; 2014 Feb; 75(2):109-16. PubMed ID: 24471746
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The effect of proteolytic inhibitors on tolerance to renal ischemia].
    Baran JJ; Petrun NM; Zybuljak JI; Nikulina GG; Krimkewitsch JI
    Z Urol Nephrol; 1983 Sep; 76(9):587-91. PubMed ID: 6196924
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A simple sprayer for the coating with EDTA of glass tubes for blood specimen collection].
    Tille D; D'Heureuse-Gerhardt R
    Z Med Labortech; 1975; 16(3):181. PubMed ID: 810987
    [No Abstract]   [Full Text] [Related]  

  • 80. [Analysis and reaction behavior of localized angiotensinase (N) in the juxtaglomerular apparatus of the rat kidney].
    Dahlheim H
    Pflugers Arch; 1972; 332():Suppl 332:R27. PubMed ID: 4340715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.